Anxiety and Sleep Disorders Therapeutics Flashcards
Medical Conditions with Secondary Anxiety Symptoms
Endocrine (thyroid or parathyroid disease, hypoglycemia, cushings)
Cardio-respiratory (angina, pulmonary embolism)
Autoimmune disorders
Neurological disorder (seizure disorder)
Substance related (nicotine, alcohol, benzos and opioids)
Medications which can cause anxiety
Stimulants, thyroid supplements, antidepressants, corticosteroids, oral contraceptives, bronchodilators, decongestants, abrupt withdrawal of CNS depressants (benzos, barbs, and alcohol)
Drug classes to treat anxiety
Antidepressants (SSRIs, SNRIs, TCAs, MAOIs)
Benzodiazepines and Z-drugs
Antihistamines, 5HT1a agonists and GABA agonists
Benzodiazepines by speed of onset
Very fast (diazepam)
Fast (Clorazepate)
Intermediate (alprazolam, chlordiazepoxide, clonazepam, lorazepam)
Slow (oxazepam)
Benzodiazepines by half-life
Short/Intermediate (alprazolam, oxazepam, lorazepam, chlordiazepoxide)
Intermediate/Long (clorazepate, diazepam)
Clomipramine is used for
OCD or panic disorder
GABA Agonist
Meprobamate
5HT1a receptor agonist
Buspirone (GAD, SAD)
MAOI
Phenelzine (SAD, Panic, PTSD, MDD)
GAD Criteria (DSM 5)
Presence of anxiety and worry for 6 months (worry when nothing is wrong or worry that is disproportionate)
With at least 3 of the following (edginess or restlessness, tiring easily/fatigued more than usual, impaired concentration, irritability, increased muscle aches or soreness, difficulty sleeping)
GAD
Generalized Anxiety Disorder
Psychic/subjective symptoms (worry, on edge, impaired concentration, concern over health)
Somatic symptoms (muscle tension, insomnia, fatigue, irritability, nausea or diarrhea, sweating, urinary frequency, palpitations, pain, GI distress)
GAD Comorbidity
90% have another psychiatric disorder
62% have lifetime MDD; 40% have dysthymia
Anxiety disorders predict greatest risk of secondary MDD
58% of patients with lifetime MDD have an anxiety disorder
Affects 6.8 million American adults (2.1%)
Overlapping MDD and GAD symptoms
Anxiety, sleep disturbance, psychomotor agitation, concentration difficulty, irritability, fatigue
HAM-A
Hamilton Anxiety Rating Scale
Good for both psychic and somatic symptoms
Pretreatment HAM-A scores of more than 18 indicate common index need for treatment
GADSS
Generalized anxiety disorder severity scale
Specific probing in domains of worry, impairment of social and work functioning
PSWQ
PENN state worry questionnaire
Measures trait-like tendency to worry excessively
Useful to test severity of pathological worry
Discriminates among anxiety disorders - higher score indicate GAD among other disorders
Non-pharm for GAD
Relaxation techniques, biofeedback to reduce arousal, cognitive therapy, behavioral therapy
Cognitive Behavioral Therapy
Talk therapy helps change thinking patterns to find ways of coping; includes relaxation techniques, problem solving and challenging distorted beliefs
GAD Medication Treatment
Benzodiazepiens (acute; most effective for somatic symptoms)
Antidepressants (long term; most effective for psychic symptoms)
GAD Treatment Plan
1st Line (CBT with or without SSRI; if partial resposne augment with buspirone, hydroxyzine, pregabalin, or benzo)
2nd line (SNRI; duloxetine or venlafaxine)
3rd line (SSRI/SNRI + SGA (risperidone, quetiapine, olanzapine))
Continue medication/therapy treatment for at least 1 year
SSRI Concerns/Benefits
Stopped abruptly SSRIs can produce discontinuation syndrome (dizziness, insomnia, flu-like symptoms, seizures)
SNRIs Concerns/Benefits
abrupt withdrawal can cause anxiety, insomnia, flu like symptoms, headache, nausea, electrical shock like symptoms down limbs and scalp
TCAs Concerns/Benefits
Potential fatal toxicity after overdose
MAOIs Concerns/Benefits
Fatal overdose potential
Benzodiazepines Concerns/Benefits
Abrupt withdrawal may cause psychosis, delirium, confusion, seizures, insomnia and agitation
Anticonvulsants Concerns/Benefits
Discontinuation symptoms and abuse have been reported
SAD
Symptoms related to social or performance (as opposed to broad in GAD) situations in which you expect scrutiny or evaluations by others
Affects 6% of adults
SAD Generalized vs non-generalized
Generalize (70% of cases), pervasive social fears and avoidance, early onset, familial, high comorbidity, more impairment, low remission, continual treatment (non-generalized is opposite)
SAD Treatment
Medication equally as effective as CBT (high effectiveness over year when used together)
CBT produces more significant results with lower rates of relapse; meds preferred if paralyzing symptoms or comorbid severe depression
SAD Treatment Plan
1st Line: SSRI
2nd Line: Different SSRI or SNRI (venlafaxine, mirtazapine); add benzo short term, augment with buspirone or beta blocker (for performance anxiety)
3rd Line (SGA - quetiapine, risperidone; MAIO - phenelzine; anticonvulsant/mood stabilizer - pregabalin, gabapentin)
Other treatment options for SAD
Combining meds (buspiron w/ SSRI or SNRI; Benzo with SSRI or SNRI; Med with CBT better than two meds)
Gabapentin is only modestly effective
Beta blockers ONLY for performance anxiety
Antipsychotics (quetiapine, risperidone) for cognitive impairment, weight gain and metabolic issues
PTSD Diagnostic criteria
History of exposure to traumatic event with attributes from each cluster:
Exposure (direct, indirect)
Intrusion (nightmares, flashbacks)
Avoidance of situations
Cognition and mood (recall problems, memory deficit)
Arousal and reactivity (irritable, aggressive, sleep disturbance)
Symptoms must last longer than 1 month, can’t be attributable to substance or co-occurring medical conditions
PTSD Common Reactions/Behaviors
Fear, helplessness, anxiety
Reliving trigger events in form of thoughts, flashbacks or dreams
Disassociation
Avoidance
Hyperarousal and exaggerated startle resposne
Occurs on a continuum with some living their entire lives in a subthreshold PTSD state